Silk-hyaluronan-based composite hydrogels: A novel, securable vehicle for drug delivery

Journal of Biomaterials Applications

Volumn 27, Issue 6, 2013, Pages 749-762

  Elia, Roberto ^a   Newhide, Danny R ^b   Pedevillano, Paul D ^a   Reiss, G Russell ^c   Firpo, Matthew A ^d   Hsu, Edward W ^e   Kaplan, David L ^a   Prestwich, Glenn D ^f   Peattie, Robert A ^a  

^a Tufts University   (United States)

^b TUFTS UNIVERSITY   (United States)

^c Milstein Hospital   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF UTAH   (United States)

^f UNIVERSITY OF UTAH   (United States)

Author keywords

Controlled drug release; cytokine; growth factors; hyaluronic acid; hydrogels; silk; vascular endothelial growth factor

Indexed keywords

CONTROLLED DRUG RELEASE; CYTOKINES; GROWTH FACTOR; HYALURONIC ACIDS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

DRUG DELIVERY; ORGANIC ACIDS; POLYETHYLENE GLYCOLS; REINFORCEMENT; SILK; TISSUE;

HYDROGELS;

BIOMATERIAL; CROSS LINKING REAGENT; CYTOKINE; FIBROIN; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; SILK; VASCULOTROPIN A;

ANIMAL; ARTICLE; BIOMECHANICS; BIOMEDICAL ENGINEERING; CHEMISTRY; DRUG DELIVERY SYSTEM; HYDROGEL; MATERIALS TESTING; METABOLISM; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMECHANICS; BIOMEDICAL ENGINEERING; CROSS-LINKING REAGENTS; CYTOKINES; DRUG DELIVERY SYSTEMS; FIBROINS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; HYDROGELS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; SILK; SURFACE PROPERTIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84872382069     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328211424516     Document Type: Article

References (52)

1. Manuskiatti W, Maibach HI. Hyaluronic acid and skin: wound healing and aging. Int J Dermatol. 1996 ; 35: 539-544
2. Paku S, Paweletz N. First steps of tumor-related angiogenesis. Lab Invest. 1991 ; 65: 334-346
3. Prestwich GD, Kuo J-W. Chemically-modified HA for therapy and regenerative medicine. Curr Pharm Biotech. 2008 ; 9: 242-245
4. Kuo JW Practical aspects of hyaluronan-based medical products. Boca Raton, FL: CRC Taylor & Francis ; 2006 :
5. Hu M, Sabelman EE, Lai S, Timek EK, Zhang F, Hentz VR, et al. Polypeptide resurfacing method improves fibroblast's adhesion to hyaluronan strands. J Biomed Mater Res. 1999 ; 47: 79-84
6. Prestwich GD. Engineering a clinically-useful matrix for cell therapy. Organogenesis. 2008 ; 4: 42-47
7. Prestwich GD. Evaluating drug toxicity and efficacy in three dimensions: using synthetic extracellular matrices in drug discovery. Acc Chem Res. 2008 ; 41: 139-148
8. Gluzman-Poltorak Z, Cohen T, Herzog Y, Neufeld G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165. J Biol Chem. 2000 ; 275: 18040-18045
9. Hosack LW, Firpo MA, Scott JA, Prestwich GD, Peattie RA. Microvascular maturity elicited in tissue treated with cytokine-loaded hyaluronan-based hydrogels. Biomaterials. 2008 ; 29: 2336-2347
10. Elia R, Fuegy PW, VanDelden A, Firpo MA, Prestwich GD, Peattie RA. Stimulation of in vivo angiogenesis byin situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. Biomaterials. 2010 ; 31 (17). 4630-4638
11. Morra M. Engineering of biomaterials surfaces by hyaluronan. Biomacromolecules. 2005 ; 6: 1205-1223
12. Shu XZ, Liu Y, Palumbo FS, Luo Y, Prestwich GD. In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials. 2004 ; 25: 1339-1348
13. Burdick J, Prestwich GD. Hyaluronic acid hydrogels for biomedical applications. Adv Mater. 2011 ; 23: H41 - H56
14. Gong JP, Katsuyama Y, Kurokawa T, Osada Y. Double-network hydrogels with extremely high mechanical strength. Adv Mater. 2003 ; 15: 1158-1158
15. Zhou C, Wu Q. Colloids and surfaces B: biointerfaces. A novel polyacrylamide nanocomposite hydrogel reinforced with natural chitosan nanofibers. Colloids Surf B Biointerfaces. 2011 ; 84: 155-162
16. Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, et al. Silk-based biomaterials. Biomaterials. 2003 ; 24: 401-416
17. Wilding MA, Hearle JWS Polymeric materials encyclopedia. Salamone JC, ed. Boca Raton, FL: CRC Press ; 1996: 8307-8322.
18. Kaplan DL, Adams WW, Farmer B, Viney C In: Kaplan D, Adams WW, Farmer B and Viney C (ed.) Silk polymers: materials science and biotechnology. ACS Symposium Series 544. Washington, DC: American Chemical Society ; 1994: 2-2.
19. Perez-Rigueiro J, Viney C, Llorca J, Elices M. Mechanical properties of silkworm silk in liquid media. Polymer. 2000 ; 41: 8433-8439
20. Wang X, Kluge J, Leisk GG, Kaplan DL. sonication-induced gelation of silk fibroin for cell encapsulation. Biomaterials. 2008 ; 29: 1054-1064
21. Horan RL, Antle K, Collette AL, Wang Y, Huang J, Moreau JE, et al. In vitro degradation of silk fibroin. Biomaterials. 2005 ; 26: 3385-3393
22. Wang Y, Rudym DD, Walsh A, Abrahamsen L, Kim H, Kim HS, et al. In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials. 2008 ; 29: 3415-3428
23. Zhang X, Baughman CB, Kaplan DL. In vitro evaluation of electrospun silk fibroin scaffolds for vascular cell growth. Biomaterials. 2008 ; 29: 2217-2227
24. Li C, Vepari C, Jin H, Kim HJ, Kaplan DL. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials. 2006 ; 27: 3115-3124
25. Min BM, Jeongb L, Nam YS, Kim JM, Kim JY, Park WH. Formation of silk fibroin matrices with different texture and its cellular response to normal human keratinocytes. Int J BiolMacromol. 2004 ; 34: 281-288
26. Schneider A, Wang XY, Kaplan DL, Garlick JA, Egles C. Biofunctionalized electrospun silk mats as a topical bioactive dressing for accelerated wound healing. Acta Biomater. 2009 ; 5: 2570-2578
27. Jin H, Fridrikh SV, Rutledge GC, Kaplan DL. Electrospinning Bombyx mori silk with poly(ethylene oxide). Biomacromolecules. 2002 ; 3: 1233-1239
28. Jin H, Chen J, Karageorgiou V, Altman GH, Kaplan DL. Human bone marrow stromal cell responses on electrospun silk fibroin mats. Biomaterials. 2004 ; 25: 1039-1047
29. Wilson D, Valluzzi R, Kaplan DL. Conformational transitions in model silk peptides. Biophys J. 2000 ; 78: 2690-2701
30. Band PA. Chemistry and clinical applications. In: Laurent TC (ed.) The chemistry, biology and medical applications of hyaluronan and its derivatives. London, UK: Portland Press Ltd., 1998, pp. 33-42.
31. Fraser JRE, Laurent TC, Laurent UBG. Hyaluronan: its nature, distribution, function and turnover. J Intern Med. 1997 ; 242: 27-33
32. Luo Y, Kirker KR, Prestwich GD. Cross-linked hyaluronic acid hydrogel films: new biomaterials for drug delivery. J Control Rel. 2000 ; 69: 169-184
33. Pike DB, Cai S, Pomraning KR, Firpo MA, Fisher RJ, Shu XZ, et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials. 2006 ; 27: 5242-5251
34. Lim ST, Forbes B, Berry DJ, Martin GP, Brown MB. In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. Int J Pharm. 2002 ; 231: 73-82
35. Na K, Kim S, Woo DG, Sun BK, Yang HN, Chung HM, et al. Combination material delivery of dexamethasone and growth factor in hydrogel blended with hyaluronic acid constructs for neocartilage formation. J Biomed Mat Res A. 2007 ; 83: 779-786
36. Hahn SK, Kim JS, Shimobouji T. Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin. J Biomed Mater Res. 2007 ; 80A: 916-924
37. Prestwich GD. Hyaluronic acid-based clinical biomaterials for cell and molecule delivery in regenerative medicine. J Control Rel 2011; doi:10.1016/j.jconrel.2011.04.007.
38. Peattie R, Nayate A, Firpo M, Shelby J, Fisher R, Prestwich GD. Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials. 2004 ; 25: 2789-2798
39. Allison D, Grande-Allen K. Hyaluronan: a powerfultissue engineering tool. Tissue Eng. 2006 ; 12 (8). 2131-2140
40. Lu Q, Zhang B, Li M, Zuo B, Kaplan DL, Huang Y, et al. Degradation mechanism and control of silk fibroin. Biomacromolecules. 2011 ; 12: 1080-1086
41. Jin HJ, Park J, Karageorgiou V, Kim UJ, Valluzzi R, Kaplan DL. Water-stable silk films with reduced β-sheet content. Adv Funct Mater. 2005 ; 15: 1241-1247
42. Gil ES, Park S, Tien LW, Trimmer B, Hudson SM, Kaplan DL. Mechanically robust, rapidly actuating, and biologically functionalized macroporous poly(N-isopropylacrylamide)/silk hybrid hydrogels. Langmuir. 2010 ; 26 (19). 15614-15624
43. Beek MV, Jones L, Sheardown H. Hyaluronic acid containing hydrogels for the reduction of protein adsorption. Biomaterials. 2008 ; 29: 780-789
44. Xiao H, Kaplan D, Cebe P. Effect of water on the thermal properties of silk fibroin. Thermochim Acta. 2007 ; 461: 137-144
45. Dave V, Tamagno M, Focher B. Hyaluronic acid - (hydroxyproppyl)cellulose blends: a solution and solid state study. Macromolecules. 1995 ; 28: 3531-3539
46. Cloyd JM, Malhotra NR, Weng L, Chen W, Mauck RL, Elliott DM. Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds. Eur Spine J. 2007 ; 16: 1892-1898
47. Zhang XZ, Wu DQ, Chu CC. Synthesis, characterization and controlled drug release of thermosensitive IPN-PNIPAAm hydrogels. Biomaterials. 2004 ; 25: 3793-3805
48. Niederer SA, Buist ML, Pullan AJ and Smith NP. Calculating work in the ischemic heart. In: Proceedings of the 26th Annual IEEE Engineering and Medicine in Biology Society Conference, San Francisco, USA, September 1-5, 2004, pp. 3646-3649.
49. Peattie RA, Yu B, Cai S, Firpo MA, Pike DB, Fisher RJ, et al. Heparin regulation of cytokine release from hyaluronan-based hydrogels. Drug Deliv. 2008 ; 15: 363-371
50. Makai M, Csányi E, Németh Z, Pálinkás J, Eros I. Structure and drug release of lamellar liquid crystals containing glycerol. Int J Pharm. 2003 ; 256: 95-107
51. Cai S, Liu Y, Shu X, Prestwich GD. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials. 2005 ; 26 (30). 6054-6067
52. Wissink MJB, Beernink R, Poot AA, Engbers GHM, Beugeling T, van Aken WG, et al. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices. J Control Rel. 2000 ; 64: 103-114